China: Microport to spin-off heart valve specialists

Zhaohua Chang, chairman, executive director and chief executive officer, MicroPort

The rush to list on the HKEx continues. Microport Scientific medtech subsidiary MicroPort CardioFlow has revived plans to list that were delayed by the Covid-19 pandemic. A specialist in transcatheter aortic valve implantation, the company had intended to float in the first quarter this year. In a statement, MicroPort said that the spin-off would “unlock…

You must be a HMI Subscriber to view this content.

Subscribe Now »